Assessment of the effectiveness of Budesonide MMX(®) for active, mild-to-moderate ulcerative colitis in the Polish sub-group of the CORE Practice prospective multi-centre observational study

INTRODUCTION: Budesonide MMX(®) is approved for induction of remission in mild-to-moderate active ulcerative colitis (UC) in adults in whom 5-ASA is not sufficient. There is a lack of data on its effectiveness and safety in clinical practice. MATERIAL AND METHODS: The CORE Practice study was a multi...

Descripción completa

Detalles Bibliográficos
Autores principales: Jesionowski, Maciej, Rydzewska, Grażyna, Danese, Silvio, Paridaens, Kristine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2023
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395053/
https://www.ncbi.nlm.nih.gov/pubmed/37538282
http://dx.doi.org/10.5114/pg.2023.129413

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395053/
https://www.ncbi.nlm.nih.gov/pubmed/37538282
http://dx.doi.org/10.5114/pg.2023.129413

Ejemplares similares